CNB Bank decreased its position in Lam Research Corporation (NASDAQ:LRCX – Free Report) by 5.7% in the second quarter, according to its most recent 13F filing with the SEC. The firm owned 10,357 shares of the semiconductor company’s stock after selling 626 shares during the period. CNB Bank’s holdings in Lam Research were worth $1,008,000 at the end of the most recent reporting period.
A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in LRCX. BankPlus Wealth Management LLC lifted its position in shares of Lam Research by 2.0% during the second quarter. BankPlus Wealth Management LLC now owns 5,248 shares of the semiconductor company’s stock worth $511,000 after purchasing an additional 105 shares in the last quarter. ORG Partners LLC raised its stake in shares of Lam Research by 7.3% during the second quarter. ORG Partners LLC now owns 1,676 shares of the semiconductor company’s stock worth $162,000 after buying an additional 114 shares during the last quarter. Quotient Wealth Partners LLC raised its stake in shares of Lam Research by 2.1% during the second quarter. Quotient Wealth Partners LLC now owns 5,437 shares of the semiconductor company’s stock worth $529,000 after buying an additional 114 shares during the last quarter. Fairvoy Private Wealth LLC increased its stake in Lam Research by 3.0% in the second quarter. Fairvoy Private Wealth LLC now owns 4,185 shares of the semiconductor company’s stock valued at $407,000 after purchasing an additional 120 shares in the last quarter. Finally, Rosenberg Matthew Hamilton increased its stake in Lam Research by 16.0% in the second quarter. Rosenberg Matthew Hamilton now owns 869 shares of the semiconductor company’s stock valued at $85,000 after purchasing an additional 120 shares in the last quarter. Institutional investors and hedge funds own 84.61% of the company’s stock.
Lam Research Stock Up 2.8%
NASDAQ:LRCX opened at $151.68 on Friday. The firm’s 50 day simple moving average is $123.23 and its 200 day simple moving average is $99.60. The company has a debt-to-equity ratio of 0.37, a current ratio of 2.21 and a quick ratio of 1.55. Lam Research Corporation has a one year low of $56.32 and a one year high of $153.70. The company has a market cap of $191.27 billion, a PE ratio of 33.41, a P/E/G ratio of 1.76 and a beta of 1.84.
Lam Research Increases Dividend
The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, October 15th. Shareholders of record on Wednesday, September 24th were issued a dividend of $0.26 per share. The ex-dividend date was Wednesday, September 24th. This is a positive change from Lam Research’s previous quarterly dividend of $0.23. This represents a $1.04 annualized dividend and a yield of 0.7%. Lam Research’s dividend payout ratio is currently 22.91%.
Insiders Place Their Bets
In other Lam Research news, SVP Vahid Vahedi sold 52,190 shares of the company’s stock in a transaction on Monday, October 13th. The shares were sold at an average price of $138.90, for a total transaction of $7,249,191.00. Following the transaction, the senior vice president owned 251,047 shares in the company, valued at approximately $34,870,428.30. This represents a 17.21% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Insiders own 0.31% of the company’s stock.
Wall Street Analyst Weigh In
Several brokerages have commented on LRCX. HSBC set a $127.00 target price on shares of Lam Research and gave the company a “hold” rating in a research note on Tuesday, September 30th. Mizuho upped their target price on shares of Lam Research from $162.00 to $170.00 and gave the company an “outperform” rating in a research note on Thursday. Barclays set a $142.00 target price on shares of Lam Research and gave the company an “equal weight” rating in a research note on Monday. Needham & Company LLC increased their price objective on shares of Lam Research from $150.00 to $160.00 and gave the stock a “buy” rating in a research report on Thursday. Finally, UBS Group set a $165.00 price objective on shares of Lam Research and gave the stock a “buy” rating in a research report on Thursday. One investment analyst has rated the stock with a Strong Buy rating, twenty-six have assigned a Buy rating and eight have given a Hold rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $147.21.
View Our Latest Stock Analysis on Lam Research
Lam Research Company Profile
Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits. The company offers ALTUS systems to deposit conformal films for tungsten metallization applications; SABRE electrochemical deposition products for copper interconnect transition that offers copper damascene manufacturing; SOLA ultraviolet thermal processing products for film treatments; and VECTOR plasma-enhanced CVD ALD products.
See Also
- Five stocks we like better than Lam Research
- Upcoming IPO Stock Lockup Period, Explained
- MarketBeat Week in Review – 10/20 – 10/24
- Best ESG Stocks: 11 Best Stocks for ESG Investing
- Rayonier-PotlatchDeltic Merger Signals Industry Upside
- How to trade penny stocks: A step-by-step guide
- Hims & Hers Short Interest Nears All-Time High, Buy The Dip?
Want to see what other hedge funds are holding LRCX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Lam Research Corporation (NASDAQ:LRCX – Free Report).
Receive News & Ratings for Lam Research Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lam Research and related companies with MarketBeat.com's FREE daily email newsletter.
